Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Takeyuki, Hiramatsu"'
Autor:
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Asami Takeda, Shunya Uchida, Tatsuo Tsukamoto, Kazuhiko Tsuruya, Yasuhiro Akai, Kosaku Nitta, Megumu Fukunaga, Hiroki Hayashi, Kosuke Masutani, Takashi Wada, Tsuneo Konta, Ritsuko Katafuchi, Saori Nishio, Shunsuke Goto, Hirofumi Tamai, Arimasa Shirasaki, Tatsuya Shoji, Kojiro Nagai, Tomoya Nishino, Kunihiro Yamagata, Junichiro J. Kazama, Keiju Hiromura, Hideo Yasuda, Makoto Mizutani, Tomohiko Naruse, Takeyuki Hiramatsu, Kunio Morozumi, Hiroshi Sobajima, Yosuke Saka, Eiji Ishimura, Daisuke Ichikawa, Takashi Shigematsu, Tadashi Sofue, Shouichi Fujimoto, Takafumi Ito, Hiroshi Sato, Ichiei Narita, Yoshitaka Isaka, JNSCS Investigators
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Previous studies reported conflicting results regarding an association between serum albumin concentration and the cumulative incidence of remission of proteinuria in adult patients with minimal change disease (MCD). The present study aimed
Externí odkaz:
https://doaj.org/article/fde5441cddc64b2dbe2584934829845b
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Background Oral disease may be increased in people with end-stage renal disease and associated with inflammation, cardiovascular disease, and mortality. Moreover, oral disease may be essential to decide the prognosis of peritoneal dialysis (
Externí odkaz:
https://doaj.org/article/efbc3f5e48ea43e6aeea122fc1c866dd
Autor:
Yuuki Iida, Kumiko Hongo, Takanobu Onoda, Yusuke Kita, Yukio Ishihara, Naoki Takabayashi, Ryo Kobayashi, Takeyuki Hiramatsu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore in
Externí odkaz:
https://doaj.org/article/bac3800431be4e28a6d87007f99403b3
Autor:
Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, Ryuichi Sakate, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Toshinobu Sato, Takashi Wada, Hiroki Hayashi, Yasuhiro Akai, Megumu Fukunaga, Kazuhiko Tsuruya, Kosuke Masutani, Tsuneo Konta, Tatsuya Shoji, Takeyuki Hiramatsu, Shunsuke Goto, Hirofumi Tamai, Saori Nishio, Kojiro Nagai, Kunihiro Yamagata, Hideo Yasuda, Shizunori Ichida, Tomohiko Naruse, Tomoya Nishino, Hiroshi Sobajima, Toshiyuki Akahori, Takafumi Ito, Yoshio Terada, Ritsuko Katafuchi, Shouichi Fujimoto, Hirokazu Okada, Tetsushi Mimura, Satoshi Suzuki, Yosuke Saka, Tadashi Sofue, Kiyoki Kitagawa, Yoshiro Fujita, Makoto Mizutani, Naoki Kashihara, Hiroshi Sato, Ichiei Narita, Yoshitaka Isaka
Publikováno v:
Clinical and Experimental Nephrology. 26:1170-1179
Background Prognosis of nephrotic syndrome has been evaluated based on pathological diagnosis, whereas its clinical course is monitored using objective items and the treatment strategy is largely the same. We examined whether the entire natural histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cd5e11d581466dce2fa2e7dfc8f687
https://doi.org/10.1007/s10157-022-02256-3
https://doi.org/10.1007/s10157-022-02256-3
Autor:
Naoki Takabayashi, Yuuki Iida, Ryo Kobayashi, Takeyuki Hiramatsu, Yusuke Kita, Kumiko Hongo, Takanobu Onoda, Yukio Ishihara
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific Reports
Scientific Reports
Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d85253a051a367049c476bd603c290
https://doaj.org/article/bac3800431be4e28a6d87007f99403b3
https://doaj.org/article/bac3800431be4e28a6d87007f99403b3
Autor:
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Asami Takeda, Shunya Uchida, Tatsuo Tsukamoto, Kazuhiko Tsuruya, Yasuhiro Akai, Kosaku Nitta, Megumu Fukunaga, Hiroki Hayashi, Tatsuya Shoji, Kosuke Masutani, Tsuneo Konta, Ritsuko Katafuchi, Saori Nishio, Takashi Wada, Shunsuke Goto, Hirofumi Tamai, Arimasa Shirasaki, Kojiro Nagai, Tomoya Nishino, Kunihiro Yamagata, Junichiro J. Kazama, Keiju Hiromura, Hideo Yasuda, Tadashi Sofue, Shouichi Fujimoto, Makoto Mizutani, Tomohiko Naruse, Takeyuki Hiramatsu, Kunio Morozumi, Hiroshi Sobajima, Yosuke Saka, Eiji Ishimura, Takafumi Ito, Daisuke Ichikawa, Takashi Shigematsu, Hiroshi Sato, Ichiei Narita, Isaka Yoshitaka
Publikováno v:
Kidney international reports. 7(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4f33fc8797c09965581f0dc3b616da
https://pubmed.ncbi.nlm.nih.gov/36217532
https://pubmed.ncbi.nlm.nih.gov/36217532
Autor:
Yoshitaka Isaka, Hajime Hasegawa, Takeyuki Hiramatsu, Hitoshi Yokoyama, Ichiei Narita, Naoki Kashihara, Kosuke Masutani, Seiichi Matsuo, Kunihiro Yamagata, Tatsuo Tsukamoto, Hiroshi Sato, Kazuhiko Tsuruya, Yusuke Suzuki, Tomohiko Naruse, Shoichi Maruyama, Hiroshi Sobajima, Shunsuke Goto, Arimasa Shirasaki, Hideo Yasuda, Hirofumi Tamai, Hirokazu Okada, Shunya Uchida, Makoto Mizutani, Takashi Wada, Kiyoki Kitagawa, Satoshi Suzuki, Toshinobu Sato, Keiju Hiromura, Saori Nishio, Yoshio Terada, Kosaku Nitta, Ritsuko Katafuchi, Tomoya Nishino, Eiji Ishimura, Kojiro Nagai, Tsuneo Konta, Tetsushi Mimura, Yugo Shibagaki, Kunio Morozumi, Junichiro James Kazama, Hiroki Hayashi, Hitoshi Sugiyama, Megumu Fukunaga, Shizunori Ichida, Yasuhiro Akai, Toshiyuki Akahori, Takashi Shigematsu, Takafumi Ito, Asami Takeda, Enyu Imai, Satoshi Tanaka, Tatsuya Shoji, Yoshiro Fujita, Tadashi Sofue, Yosuke Saka, Ryohei Yamamoto, Shouichi Fujimoto
Publikováno v:
Clinical and Experimental Nephrology
Background Despite recent advances in immunosuppressive therapy for patients with primary nephrotic syndrome, its effectiveness and safety have not been fully studied in recent nationwide real-world clinical data in Japan. Methods A 5-year cohort stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16900983b8341b546a8369c52cff4700
http://ir.lib.shimane-u.ac.jp/52731
http://ir.lib.shimane-u.ac.jp/52731
Autor:
Ryosuke Kikuchi, Naoki Takabayashi, Yuhi Yoshizaki, Yukio Ishihara, Takanobu Onoda, Takeyuki Hiramatsu
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 81:1597-1603
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d25d408aaf2d238e8242c1a28f29c04a
https://doi.org/10.3919/jjsa.81.1597
https://doi.org/10.3919/jjsa.81.1597
Autor:
Ryohei, Yamamoto, Enyu, Imai, Shoichi, Maruyama, Hitoshi, Yokoyama, Hitoshi, Sugiyama, Asami, Takeda, Tatsuo, Tsukamoto, Shunya, Uchida, Kazuhiko, Tsuruya, Tatsuya, Shoji, Hiroki, Hayashi, Yasuhiro, Akai, Megumu, Fukunaga, Tsuneo, Konta, Saori, Nishio, Shunsuke, Goto, Hirofumi, Tamai, Kojiro, Nagai, Ritsuko, Katafuchi, Kosuke, Masutani, Takashi, Wada, Tomoya, Nishino, Arimasa, Shirasaki, Hiroshi, Sobajima, Kosaku, Nitta, Kunihiro, Yamagata, Junichiro J, Kazama, Keiju, Hiromura, Hideo, Yasuda, Makoto, Mizutani, Toshiyuki, Akahori, Tomohiko, Naruse, Takeyuki, Hiramatsu, Kunio, Morozumi, Tetsushi, Mimura, Yosuke, Saka, Eiji, Ishimura, Hajime, Hasegawa, Daisuke, Ichikawa, Takashi, Shigematsu, Hiroshi, Sato, Ichiei, Narita, Yoshitaka, Isaka, Hiroyuki, Komatsu
Publikováno v:
Journal of nephrology. 35(4)
Minimal change disease (MCD) is characterized by a nephrotic syndrome usually steroid-sensitive and a high incidence of relapse of proteinuria. Previous cohort studies have reported conflicting results regarding the association between the time to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54f78b7296f5ba2e25083254b7f2c01a
https://pubmed.ncbi.nlm.nih.gov/35366214
https://pubmed.ncbi.nlm.nih.gov/35366214
Autor:
Soichiro Ishihara, Takeyuki Hiramatsu, Kazushige Kawai, Yusuke Kita, Yukio Ishihara, Kumiko Hongo, Naoki Takabayashi, Kazuaki Okamoto, Kazuhito Sasaki, Koji Murono, Hiroaki Nozawa, Ryo Kobayashi, Yuuki Iida
Publikováno v:
International journal of clinical oncology. 26(8)
FOLFOX therapy, a standard treatment for colorectal cancer (CRC), causes a rare, but serious adverse event, hyperammonemia. However, the risk factors of hyperammonemia remain unknown. We examined 74 patients who received mFOLFOX6 therapy with or with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e810f0a6e276ca4ec2c595cb7cf9a1b9
https://pubmed.ncbi.nlm.nih.gov/33991268
https://pubmed.ncbi.nlm.nih.gov/33991268